BioJapan 2027【Kanagawa Prefecture】
BioJapan 2027 will take place October 13–15, 2027 (Wednesday–Friday), at PACIFICO Yokohama in Yokohama, Kanagawa Prefecture, Japan. One of Asia’s largest bio-industry partnering events, it brings together BioJapan, Regenerative Medicine Japan 2027 and healthTECH JAPAN 2027. Through exhibitions, seminars and one-on-one partnering meetings, the event connects pharmaceutical companies, biotechnology startups, universities, research institutions and investors from Japan and around the world. Its scope includes biopharmaceuticals, drug discovery services, contract development and manufacturing (CDMO), regenerative medicine, cell and gene therapy, research instruments and reagents, and digital health. Exhibitor applications for the 2027 event are scheduled to open in December 2026.
10:00–17:00
About BioJapan and Its Objectives
First held in 1986, BioJapan is a long-established international biotechnology event. It promotes open innovation across the bio-industry and provides opportunities for commercializing research, forming technology partnerships, pursuing joint research, licensing technologies and securing investment.
Three Pillars of the Event
- Exhibition: Showcase products, services and research outcomes while connecting with potential customers and collaborators.
- Seminars: Insights into scientific research, emerging technologies and industry trends from experts and companies in Japan and overseas.
- Partnering: Search for potential business partners, request appointments and conduct one-on-one meetings through a dedicated partnering system.
Beyond scientific and technical exchange, BioJapan serves as a business platform that facilitates business development and technology transfer.
Official information: About BioJapan and the Three Pillars of the Event
BioJapan 2027: Event Information
- Official Name: BioJapan 2027.
- Concurrent Shows: Regenerative Medicine Japan 2027 and healthTECH JAPAN 2027.
- Dates: October 13–15, 2027 (Wednesday–Friday).
- Opening Hours: 10:00–17:00.
- Venue: PACIFICO Yokohama.
- Address: 1-1-1 Minatomirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan.
- Organizers: BioJapan Organizing Committee, represented by the Japan Bioindustry Association (JBA), and JTB Communication Design, Inc.
- Event Components: Exhibition, seminars and partnering.
- Target Participants: Pharmaceutical and biotechnology companies, drug discovery service providers, universities, research institutions, healthcare organizations, investors and government or public support organizations.
Official information: 2027 Event Overview
Concurrent Shows and Organizers
BioJapan 2027
BioJapan covers a broad range of industrial biotechnology applications, including pharmaceuticals, drug discovery, research instruments and reagents, biomanufacturing, food, the environment and energy. It is organized by the BioJapan Organizing Committee, represented by JBA, and JTB Communication Design.
Regenerative Medicine Japan 2027
This exhibition promotes research, development and commercialization in regenerative medicine, including iPS cells, ES cells, stem cell research, cell culture, cell processing, gene therapy and regenerative medicine products. Its organizers are the Forum for Innovative Regenerative Medicine (FIRM), JBA and JTB Communication Design.
healthTECH JAPAN 2027
This exhibition focuses on the integration of life sciences with digital technologies and data. Relevant areas include AI-enabled drug discovery, digital diagnostics, digital biomarkers, wearable devices and digital therapeutics. It is organized by JBA and JTB Communication Design.
Official information: Exhibition Themes and Organizers
Key Exhibition Areas and Technologies
The following are major life science and biopharmaceutical industry areas based on the official exhibition categories.
- Pharmaceuticals and Drug Discovery: Small and middle molecules, biologics, therapeutic antibodies, biosimilars, drug delivery systems (DDS) and drug discovery screening.
- Biopharmaceutical Manufacturing and Contract Services: CMOs, CDMOs, CROs, contract analytical services, manufacturing facilities and bioprocess technologies.
- Research Instruments, Reagents and Consumables: Cell culture systems, analytical instruments, research reagents, culture media, imaging systems, bioinformatics and research support services.
- Regenerative Medicine and Cell and Gene Therapy: iPS cells, ES cells, cell processing, 3D culture, gene editing, gene therapy, cell preservation and transport, and quality assessment.
- Diagnostics and Medical Devices: Genetic diagnostics, diagnostic imaging, biomarkers, biosensors and medical devices.
- Digital Health and AI: AI-enabled drug discovery, genomic data analysis, digital biomarkers, digital therapeutics and healthcare data applications.
- Biomanufacturing, Food and the Environment: Functional foods, agriculture, forestry and fisheries, biorefining, biofuels, biomass plastics and environmental technologies.
Pharma Nexus highlights: Particular attention can be given to single-use technologies for biopharmaceutical manufacturing, automated cell manufacturing, upstream and downstream bioprocesses, quality control, and emerging research technologies such as spatial proteomics, organoids and single-cell analysis. These fields connect challenges in research and development with manufacturing and commercialization. They are related technology areas identified by Pharma Nexus, not confirmed individual products to be exhibited in 2027.
Official information: Exhibition and Visitor Categories
Partnering and One-on-One Business Meetings
A distinctive feature of BioJapan is its dedicated partnering system, which enables participants to arrange business meetings in advance. Participants can search company and research institution profiles, request appointments with potential partners and hold individual meetings during the event.
- Joint Research and Development: Research partnerships with pharmaceutical companies, biotechnology startups, universities and research institutions.
- Licensing and Technology Transfer: Opportunities for in-licensing and out-licensing drug discovery assets, research outcomes and technologies.
- Product and Service Proposals: Introduce research instruments, reagents, CDMO and CRO services, and other research support solutions.
- Business Partnerships and Investment: Exchange information with collaborators, distribution partners and investors.
The usual process involves visitor registration, partnering registration, profile creation, partner searches, meeting requests and individual meetings. The dedicated system also assists with scheduling appointments.
The 2027 partnering registration opening date, fees, early-bird discounts, system availability period and meeting duration are under preparation. The 2026 fees and schedules displayed on the official website should not be treated as confirmed arrangements for 2027.
Official information: Partnering System and Participation Information
Seminars and Presentation Program
BioJapan features organizer seminars, sponsored seminars, luncheon seminars and exhibitor presentations covering research, technology and business developments across the bio-industry.
- Organizer Seminars: Expert presentations on research and development, commercialization and industry trends.
- Sponsored Seminars: Company presentations on technologies, research strategies and business partnerships.
- Exhibitor Presentations: Research findings, products and services presented by companies, universities and research institutions.
- Detailed 2027 Program: Under preparation.
- Seminar Reservations and Presentation Application Requirements: 2027 details under preparation.
Please consult the forthcoming official program for 2027 lecture topics, speakers, venues, session counts and attendance requirements. Previous seminar programs and presentation fees have not been applied to the 2027 event.
Official information: Seminars and Presentations
Visitor Registration and Participation Fees
BioJapan distinguishes regular exhibition attendance from paid partnering participation. Official registration dates and fees for the 2027 event are under preparation.
| Participation Category | 2027 Status |
|---|---|
| General Visitor Registration and Admission | Under preparation |
| Partnering Registration and Fees | Under preparation |
| Seminar Reservations | Under preparation |
| Exhibitor Directory and Floor Map | 2027 editions under preparation |
Reference: 2026 Participation Arrangements. General exhibition admission was free with advance registration, and the standard partnering fee was JPY 165,000 per account, including tax. These are 2026 arrangements, not confirmed fees for 2027.
The official website still contains links to the 2026 visitor registration system. Please verify the event year before completing registration once applications for 2027 open.
Official information: Visitor Information / Partnering Registration Information
Corporate Exhibitions, Sponsorship and Previous Event Results
Exhibitor applications for BioJapan 2027 are scheduled to open in December 2026. The official exhibitor information states that exhibition plans, pricing and preparation schedules will be updated when applications open.
- Exhibitor Applications Open: December 2026 (scheduled).
- Application and Early-Bird Discount Deadlines: Under preparation.
- Exhibition Fees and Booth Specifications: 2027 details under preparation.
- Sponsored Seminars and Exhibitor Presentations: 2027 application requirements and fees under preparation.
- Reference Exhibition Plans: The 2026 event offered Standard Plans, Startup Plans, Universities and Technical College Plans, and meeting booths in the partnering area. Please confirm the official 2027 plans once applications open.
Reference: 2026 Event Results (Preliminary Visitor Count)
| 2026 Event Date | Visitor Count |
|---|---|
| October 7 (Wednesday) | 8,911 |
| October 8 (Thursday) | 8,154 |
| October 9 (Friday) | 5,770 |
| Three-Day Total | 22,835 |
The preliminary 2026 visitor count covers all concurrent shows and represents 103% of the previous year’s figure. These preliminary figures may be revised and are not projected attendance figures for 2027.
Pharma Nexus highlights: Companies presenting technologies to research and business development professionals at pharmaceutical companies and biotechnology startups may consider combining exhibition booths with advance partnering appointments and seminar presentations. Please consult the official 2027 exhibitor requirements before applying.
Inquiries: JTB Communication Design, Inc.
BioJapan: biojapan@jtbcom.co.jp
Regenerative Medicine Japan: saisei@jtbcom.co.jp
healthTECH JAPAN: healthtech@jtbcom.co.jp
Official information: 2027 Exhibitor Applications and Inquiries / 2026 Preliminary Visitor Count
Venue and Access
PACIFICO Yokohama
1-1-1 Minatomirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan.
- Minatomirai Station, Minatomirai Line: Approximately five minutes on foot.
- Sakuragicho Station, JR and Yokohama Municipal Subway: Approximately 12 minutes on foot.
- By Car: Approximately two minutes from the Minatomirai exit of the Metropolitan Expressway Kanagawa Route 1 Yokohane Line.
Please consult forthcoming official announcements for the 2027 exhibition halls, partnering areas, seminar venues, registration locations and accommodation information. Travel times are estimates based on the official event access guide.
Official information: BioJapan Venue and Transportation Guide
Official Websites
BioJapan 2027 Official Website
Event Overview and Concurrent Shows
Exhibitor Applications and Exhibition Information
Partnering and Business Meetings
Visitor Registration and Participation
BioJapan Official Website (Japanese)
Information checked November 13, 2026. The 2027 dates, opening hours, venue, concurrent shows and scheduled opening of exhibitor applications are based on the organizers’ official announcements. Exhibition fees, visitor registration, partnering fees and the detailed seminar program for 2027 are under preparation. The 2026 fees and visitor results are provided separately for reference. Please consult the official website for the latest information.
